Glaucoma
Conditions
Keywords
knowledge, psychology
Brief summary
This study will compare the glaucoma day-ward patients' efficacy with inpatients by evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the differences. Half of participants will receive treatment in day-ward, while the other half will receive treatment in hospital.
Detailed description
Ophthalmic surgery has short operative time, quick recovery, and small anesthesia risk, making day case surgery the main management mode of ophthalmic surgery. This study will explore the differences of psychology and glaucoma knowledge between glaucoma day-ward patients and the inpatients. The data will be collected by scale on admission and discharge.
Interventions
OTHERrandomized to day ward
Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge
OTHERrandomized to inpaitent
Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge
Sponsors
Zhongshan Ophthalmic Center, Sun Yat-sen University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Patient is diagnosed with glaucoma; 2. Will receive glaucoma surgery; 3. Voluntary participation in this study; 4. Have enough language comprehension ability; 5. Best corrected visual acuity reach 0.1 or better; 6. Patient or his legal representative has sign the informed consent.
Exclusion criteria
1. Patient with mental disorder; 2. There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases; 3. Patient with monocular blindness; 4. Axial length≤20 mm; 5. With other serious eye diseases; 6. Neurologic diseases that could affect the visual field; 7. 3 months prior to research to participate in any clinical study; 8. Researchers think not suitable to participate in this clinical trial subjects; 9. Refused to sign the informed consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of depression and anxiety score | at baseline and 1 hour before discharge | The outcome will be measured by The Hospital Depression and Anxiety Scale (HADS). It consists of two subscales: HDAS-anxiety and HADS-depression. Each item is srored from 0-3, with higher scores indicating a higher level of depression and anxiety. For each of the seven-item subscales, the minimum sum score is 0, and the maximum is 21. |
| Change of glaucoma knowledge score | at baseline and 1 hour before discharge | The outcome will be measured by The Gray Glaucoma Knowledge Questionaire. This quesionanire has a total maximum score of 17, with higher scores representing better knowledge. |
Countries
China
Outcome results
None listed